Literature DB >> 33450478

Semi-synthesis of N-alkyl-kappa-carrageenan derivatives and evaluation of their antibacterial activity.

Edson Hipólito Júnior1, Alan G Gonçalves2, Miguel D Noseda3, Maria Eugênia R Duarte3, Fábio S Murakami2, Diogo R B Ducatti4.   

Abstract

In this article, we describe the semi-synthesis of N-alkyl-kappa-carrageenan derivatives and their antibacterial activity against Staphylococcus aureus (ATCC 6538), Escherichia coli (ATCC 8739), and Pseudomonas aeruginosa (ATCC 9027). Kappa-carrageenan was submitted to partial acid hydrolysis promoting the selective cleavage of α-glycosidic bonds involving 3,6-anhydro-α-D-Galp units, giving rise to reducing low-molecular weight polysaccharide fragments, which were reacted with alkylamines of varying chain lengths by reductive amination. The carrageenan derivatives were characterized by HPSEC-MALLS-RID and 1D and 2D 1H and 13C NMR spectroscopy. The antibacterial activity of N-alkyl-kappa-carrageenan derivatives was compared with N-alkyl-(1-deoxylactitol-1-yl)-amines using a microdilution test, which indicated that inhibitory activity was dependent on the degree of substitution by hydrophobic groups at the polysaccharide structure. Comparing the effect of different N-alkyl chains, those with longer chains showed higher activity.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibacterial activity; Kappa-carrageenan; N-Alkyl-(1-deoxylactitol-1-yl)-amines; Partial acid hydrolysis; Polysaccharide modification; Seaweed polysaccharide

Year:  2021        PMID: 33450478     DOI: 10.1016/j.carres.2021.108234

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  2 in total

1.  Sulfated Polysaccharides Derived from Hypnea valentiae and Their Potential of Antioxidant, Antimicrobial, and Anticoagulant Activities with In Silico Docking.

Authors:  Kokila Palani; Balamuralikrishnan Balasubramanian; Arunkumar Malaisamy; Viji Maluventhen; Vijaya Anand Arumugam; Naif Abdullah Al-Dhabi; Mariadhas Valan Arasu; Karthika Pushparaj; Wen-Chao Liu; Maruthupandian Arumugam
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-20       Impact factor: 2.650

Review 2.  The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review.

Authors:  Andri Frediansyah
Journal:  Clin Epidemiol Glob Health       Date:  2021-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.